Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-042621
Filing Date
2017-06-30
Accepted
2017-06-30 19:59:31
Documents
1
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18638
  Complete submission text file 0001209191-17-042621.txt   20155
Mailing Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
QUIDEL CORP /DE/ (Issuer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O QUIDEL CORPORATION 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
BRYANT DOUGLAS C (Reporting) CIK: 0001406652 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-10961 | Film No.: 17943749